Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients - real world global study analyses

被引：0

作者：

Atreya, R. ^{[1
]}

Redondo, I. ^{[2
]}

Hill, J. ^{[3
]}

Streit, P. ^{[4
]}

Hartz, S. ^{[5
]}

Knight, H. ^{[6
]}

Barlow, S. ^{[6
]}

Hennessy, F. ^{[6
]}

Hunter, T. ^{[7
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Med Dept, Erlangen, Germany

[2] Eli Lilly & Co, Int Med, Lisbon, Portugal

[3] Eli Lilly & Co, Int PRA, Bracknell, Berks, England

[4] Eli Lilly & Co, Global PRA, Vernier, Switzerland

[5] Eli Lilly & Co, Global Patient Outcomes Real World Evidence, Bracknell, Berks, England

[6] Adelphi Real World, Real World Evidence, Bollington, England

[7] Eli Lilly & Co, Global Patient Outcomes Real World Evidence, Indianapolis, IN USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P261

引用

页码：I302 / I303

页数：2